Thyme Care is a leading value-based care enabler that collaborates with payers and providers to enhance the experience and outcomes for individuals living with cancer. The company partners with health plans, employers, and risk-bearing providers to ensure accountability for improved care quality, better health outcomes, and reduced total care costs. Through a hybrid collaborative care model, Thyme Care integrates technology-enabled care teams with providers to guide and support the entire patient journey, leveraging advanced data analytics and virtual patient engagement to drive superior care and outcomes in value-based arrangements.
Estimated Valuation
Powered by
Leadership & Board
Latest Estimated Valuation
- Estimated Valuation
- $2B
- Total Amount Raised
- $222M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $125M
- Latest Funding Round
- Series E
- Post-Money Valuation
- $2B
Main Enterprise Clients
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 02, 2026 | Series E | $125.00M | $2.00B |
| Sep 25, 2025 | Series D | $97.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Morgan Health | Series E |
| Humana | Series E |
| CVS Health Ventures | Series E |
| AlleyCorp | Series E |
| HealthQuest Capital | Series E |
| Foresite Capital | Series E |
| Concord Health Partners | Series E |
| Frist Cressey Ventures | Series E |
Similar Companies
A snapshot of private companies similar to Thyme Care, helping you discover and navigate related company profiles.
Related News and Analysis
